KOREA PHARMA Co., Ltd. (KOSDAQ:032300)

South Korea flag South Korea · Delayed Price · Currency is KRW
13,520
+20 (0.15%)
Last updated: Oct 29, 2025, 2:06 PM KST
0.15%
Market Cap145.28B
Revenue (ttm)85.34B
Net Income (ttm)1.45B
Shares Out10.91M
EPS (ttm)132.69
PE Ratio100.39
Forward PEn/a
Dividend50.00 (0.37%)
Ex-Dividend DateDec 27, 2024
Volume7,641
Average Volume9,392
Open13,470
Previous Close13,500
Day's Range13,360 - 13,520
52-Week Range12,900 - 23,650
Beta1.17
RSI31.30
Earnings Daten/a

About KOREA PHARMA

KOREA PHARMA Co., Ltd. . produces pharmaceutical drugs. The company offers amino acid, antibiotic, antidotal, antiepileptic, antihistamine, anti-inflammatory, antimicrobial, antiplatelet, circulatory system, CNS, dermatological, endocrine, gastrointestinal, hepatic, hormonal, respiratory, sympathomimetic, skeltal muscle relaxants, and specialty drugs, as well as multivitamins, and vitamin B1, etc. KOREA PHARMA Co., Ltd. was founded in 1974 and is based in Seoul, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1974
Employees 134
Stock Exchange KOSDAQ
Ticker Symbol 032300
Full Company Profile

Financial Performance

In 2024, KOREA PHARMA's revenue was 81.28 billion, a decrease of -2.36% compared to the previous year's 83.24 billion. Earnings were 3.79 billion, an increase of 4426.69%.

Financial Statements

News

There is no news available yet.